Kremen (Krm) was originally discovered as a novel transmembrane protein containing the kringle domain. Both
Introduction
The [2] , and this observation provided a convenient assay to study components of the Wnt signalling pathway.
Axis duplication was also induced by disheveled, ␤-catenin (the vertebrate homolog of armadillo), and a dominant-negative form of glycogen synthase kinase 3 (GSK3) (the vertebrate homolog of shaggy/zestewhite3). Independent of these studies, the adenomatous polyposis coli (APC) gene was identified in a hereditary human cancer and APC protein was thereafter found to interact with ␤-catenin. These studies provided not only a highly conserved signalling pathway activated by Wnt proteins, but also the connection between the Wnt signalling pathway and human cancer.
Kremen (Krm) was originally discovered as a novel transmembrane receptor-like protein, containing an extracellular kringle domain [3] . Later, Krm was shown to be the receptor for Dickkopf (Dkk) protein [4] [5] , and Ror transmembrane receptor tyrosine kinase [6] . Therefore, molecular cloning of novel kringle-containing proteins was thought to provide a clue to understanding hitherto unrevealed molecular mechanisms that underlie complex biological processes.
The strategy undertaken to clone cDNAs for kringle-containing proteins was based on the structure of a unique stretch of 16 or 17 amino acids in the kringle domain ( Fig. 1A and B 
Expression of Krm
During embryonic development, both krm1 and krm2 mRNAs are expressed at early developmental stages of the mouse embryo (Figs 3 and 4A) [3, 12] . During the progression of embryogenesis, these expression levels gradually increase (Fig. 4A ). krm1 mRNA is detectable in the mouse embryo in some sensory organs (optic vesicle, otic vesicle and nasal pit, etc.), and in the lungs, heart, apical ectodermal ridge (AER) and somites ( Fig. 3A-C) [3, 12, 33, 34] . The expression patterns of krm2 are similar to those of krm1 [12] . krm1 mRNA is also expressed in the floor plate, which is the region important for commissural neurons to establish the correct neuronal network connections (Fig. 3D-G (Fig. 3D-G [75] . In one study, hair follicles were newly formed after cutaneous wounding and a stem cell population was established in the regenerated hair [74, 77] . [78] . In neonatal mice lacking Tcf4, the crypt progenitor compartment is absent [79] [107, 108] . The Wnt/␤-catenin pathway contributes not only to cardiac development, but also to cardiac physiology and pathology [109] . Cardiac hypertrophy is an adaptive response of the heart to sustained pressure overload, caused by pathological stimuli, such as myocardial infarction. Because cardiac myocytes are terminally differentiated, they can only respond by hypertrophic growth [110] . In mice lacking Dv-1, the onset of pressure-overload-induced cardiac hypertrophy was attenuated when compared with wild type mice [111] . In addition, conditional overexpression of constitutively active GSK-3␤ led to regression of established pressure overload-induced hypertrophy [112] . Therefore, in cardiovascular medicine, regulation of the Wnt/␤-catenin pathway is thought to provide novel therapeutic targets for antihypertrophic therapy. Table 2 , abnormalities in the Wnt signalling pathway have been noted in a wide variety of human malignancies [78, 113, 114] . [115, 116] [117] . In cases of colorectal cancer where APC is not mutated, either Axin2 is mutated [118] , or an activating (oncogenic) mutation occurs in the ␤-catenin gene [119] . Although 
Fig. 4 (A) Expressions of krm1 mRNA in whole mouse embryos at serial developmental stages. (B) Tissue distribution of krm1 mRNA in adult mouse. (C) Change in the expression of krm1 mRNA during myogenic differentiation in C2C12 cells. Expression of krm1 mRNA in C2C12 cells cultured for various periods under conditions permissive for differentiation was analysed. (D) Expressions of krm1 mRNA in human cancer cell lines. simple duplication system. In tissues such as nervous tissue, in which differentiated cells lack the ability to duplicate, stem cells proliferate and differentiate into specific cell types. By contrast, in the simple duplication system, differentiated cells retain the ability to duplicate in response to tissue injury. The two systems cooperate in tissue homeostasis and regeneration, and the balance between the stem cell system and the simple-duplication system depends on the tissue type. For instance, liver regeneration largely depends on the simple-duplication system of differentiated hepatocytes, while hepatic stem cells participate in the renewal of hepatocytes, which occurs over a few hundred days. Since physiological attenuation or suppression of Wnt signalling is necessary for cell fate determination and differentiation, stem cells are likely to rely on the Wnt signalling pathway for maintenance at the required low-differentiation level, even in adult tissues largely composed of differentiated cells [74]. Multipotent epidermal stem cells reside in the bulge region of hair follicles, and the Wnt signalling pathway plays a key role in the activation and maintenance of bulge stem cells for progression toward hair formation and regeneration of hair follicles. Conditional deletion of the ␤-catenin gene, or transgenic expression of dominant-negative Lef1/Tcf4, in established hair follicles disrupts the process by which bulge stem cells provide hair lineage precursors

In intestinal epithelium, the proliferating crypt precursors and differentiated villus cells form a contiguous epithelial sheet of cells that is in perpetual upward motion. Stem cells reside near the bottom of the crypt and produce the transit-amplifying progenitor cells that differentiate into villus cells. Wnt/␤-catenin signalling is a dominant force in cell fate determination along the crypt-villus axis
Wnt signalling, Krm and cancer
Given the definitive roles of the Wnt/␤-catenin pathway in cell fate specification, embryogenesis and maintenance of stem cell characteristics and niche, it is conceivable that defects or deregulation of the Wnt signalling pathway may lead to the development of tumours. Although a partial list of malignant diseases associated with aberrant Wnt signalling is provided in
Involvement of the Wnt/␤-catenin pathway in malignant disease was first noted through the identification of the APC gene as a tumour suppressor gene in patients with a hereditary cancer syndrome termed familial adenomatous polyposis (FAP)
Non-neoplastic
Schizophrenia
Wnt1
Increased expression [81] Tetra-amelia phenopype Wnt3 Homozygous mutation [82] Mullerian-duct regression and virilization. Intersex phenotype Wnt4 Gene duplication [83] Familial exudative vitreoretinopathy Fz4 Loss of function [84] Osteoporosis-pseudoglioma syndrome Lrp5 Loss of function [85] A high bone mass phenotype Lrp5 Gain of function [86, 87] Robinow syndrome Ror2
Reduce or loss of function [88--91] Brachydactyly B Ror2 Gain of function [88, 91, 92] Acute lymphoblastic leukaemia Wnt5a Loss of function [93] Lung cancer WIF Hypermethylation [94] Colorectal cancer sFRP Hypermethylation [95] Non small cell lung cancer Dv3 Overexpression [96] Familial adenomatous polyposis Colorectal cancer APC Loss of function [97, 98] Hepatocellular carcinoma Axin1 Loss of function [99] Colorectal cancer. Hepatocellular carcinoma. Melanoma. Prostate cancer ␤-catenin Oncogenic mutation [100, 101] Colorectal cancer Dkk1 Hypermethylation [102] 
